메뉴 건너뛰기




Volumn 81, Issue 9, 2003, Pages 657-664

New approaches to pharmacological treatment of osteoporosis

Author keywords

Bone and bones physiopathology; Calcium, Dietary therapeutic use; Fractures pathology; Osteoblasts drug effects; Osteoclasts drug effects enzymology; Osteoporosis, Postmenopausal drug therapy; Osteoporosis drug therapy; Vitamin D therapeutic use

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CATHEPSIN K; CLODRONIC ACID; CYTOKINE; ESTROGEN; ETIDRONIC ACID; GROWTH FACTOR; IBANDRONIC ACID; PARATHYROID GLAND HORMONE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; STRONTIUM; STRONTIUM RANELATE; TIBOLONE; TILUDRONIC ACID; UNCLASSIFIED DRUG; VITAMIN D; ZOLENDRONATE;

EID: 0141989663     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (56)

References (42)
  • 2
    • 0029082311 scopus 로고
    • The insulin-like growth factor system and the coupling of formation to resorption
    • Hayden JM, Mohan S, Baylink DJ. The insulin-like growth factor system and the coupling of formation to resorption. Bone 1995;17 2 Suppl:93S-8S.
    • (1995) Bone , vol.17 , Issue.2 SUPPL.
    • Hayden, J.M.1    Mohan, S.2    Baylink, D.J.3
  • 5
    • 0037374270 scopus 로고    scopus 로고
    • Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: Randomised double blind controlled trial
    • Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.
    • (2003) BMJ , vol.326 , pp. 469
    • Trivedi, D.P.1    Doll, R.2    Khaw, K.T.3
  • 7
    • 0032583492 scopus 로고    scopus 로고
    • Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: Results from the Fracture Intervention Trial
    • Cummings SR, Black DM, Thompson DE, Applegate WB, Barrett-Connor E, Musliner TA, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077-82.
    • (1998) JAMA , vol.280 , pp. 2077-2082
    • Cummings, S.R.1    Black, D.M.2    Thompson, D.E.3    Applegate, W.B.4    Barrett-Connor, E.5    Musliner, T.A.6
  • 8
    • 0004851872 scopus 로고    scopus 로고
    • Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
    • Fracture Intervention Trial Research Group
    • Black DM, Cummings SR, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, et al. Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet 1996;48:1535-41.
    • (1996) Lancet , vol.48 , pp. 1535-1541
    • Black, D.M.1    Cummings, S.R.2    Karpf, D.B.3    Cauley, J.A.4    Thompson, D.E.5    Nevitt, M.C.6
  • 9
    • 0033552255 scopus 로고    scopus 로고
    • Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: A randomized controlled trial
    • Vertebral Efficacy With Risedronate Therapy (VERT) Study Group
    • Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, et al. Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 1999;282:1344-52.
    • (1999) JAMA , vol.282 , pp. 1344-1352
    • Harris, S.T.1    Watts, N.B.2    Genant, H.K.3    McKeever, C.D.4    Hangartner, T.5    Keller, M.6
  • 10
    • 12944291524 scopus 로고    scopus 로고
    • Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis
    • Vertebral Efficacy with Risedronate Therapy (VERT) Study Group
    • Reginster J, Minne HW, Sorensen OH, Hooper M, Roux C, Brandi ML, et al. Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporosis International 2000;11:83-91.
    • (2000) Osteoporosis International , vol.11 , pp. 83-91
    • Reginster, J.1    Minne, H.W.2    Sorensen, O.H.3    Hooper, M.4    Roux, C.5    Brandi, M.L.6
  • 13
    • 0034097152 scopus 로고    scopus 로고
    • Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis
    • Alendronate Once-Weekly Study Group 15
    • Schnitzer T, Bone HG, Crepaldi G, Adami S, McClung M, Kiel D, et al. Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group 15. Aging (Milano) 2000;12:1-12.
    • (2000) Aging (Milano) , vol.12 , pp. 1-12
    • Schnitzer, T.1    Bone, H.G.2    Crepaldi, G.3    Adami, S.4    McClung, M.5    Kiel, D.6
  • 16
    • 0033829969 scopus 로고    scopus 로고
    • A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: The prevent recurrence of osteoporotic fractures study. PROOF Study Groericanup
    • Chesnut CH 3rd, Silverman S, Andriano K, Genant H, Gimona A, Harris S, et al. A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Groericanup. American Journal of Medicine 2000;109:267-76.
    • (2000) American Journal of Medicine , vol.109 , pp. 267-276
    • Chesnut C.H. III1    Silverman, S.2    Andriano, K.3    Genant, H.4    Gimona, A.5    Harris, S.6
  • 18
    • 0033581212 scopus 로고    scopus 로고
    • Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: Results from a 3-year randomized clinical trial
    • Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators
    • Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, et al. Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 1999;282:637-45.
    • (1999) JAMA , vol.282 , pp. 637-645
    • Ettinger, B.1    Black, D.M.2    Mitlak, B.H.3    Knickerbocker, R.K.4    Nickelsen, T.5    Genant, H.K.6
  • 19
    • 0035120523 scopus 로고    scopus 로고
    • Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-Year results from the MORE trial. Multiple outcomes of raloxifene evaluation
    • Cauley JA, Norton L, Lippman ME, Eckert S, Krueger KA, Purdie DW, et al. Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Research and Treatment 2001;65:125-34.
    • (2001) Breast Cancer Research and Treatment , vol.65 , pp. 125-134
    • Cauley, J.A.1    Norton, L.2    Lippman, M.E.3    Eckert, S.4    Krueger, K.A.5    Purdie, D.W.6
  • 20
    • 0037138787 scopus 로고    scopus 로고
    • Raloxifene and cardiovascular events in osteoporotic postmenopausal women: Four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial
    • Barrett-Connor E, Grady D, Sashegyi A, Anderson PW, Cox DA, Hoszowski K, et al. Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial. JAMA 2002;287:847-57.
    • (2002) JAMA , vol.287 , pp. 847-857
    • Barrett-Connor, E.1    Grady, D.2    Sashegyi, A.3    Anderson, P.W.4    Cox, D.A.5    Hoszowski, K.6
  • 21
    • 0037125379 scopus 로고    scopus 로고
    • Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial
    • Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.
    • (2002) JAMA , vol.288 , pp. 321-333
    • Rossouw, J.E.1    Anderson, G.L.2    Prentice, R.L.3    LaCroix, A.Z.4    Kooperberg, C.5    Stefanick, M.L.6
  • 22
    • 0032972664 scopus 로고    scopus 로고
    • Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: A two-year randomised controlled trial
    • Beardsworth SA, Kearney CE, Purdie DW. Prevention of postmenopausal bone loss at lumbar spine and upper femur with tibolone: a two-year randomised controlled trial. British Journal of Obstetrics and Gynaecology 1999;106:678-83.
    • (1999) British Journal of Obstetrics and Gynaecology , vol.106 , pp. 678-683
    • Beardsworth, S.A.1    Kearney, C.E.2    Purdie, D.W.3
  • 23
    • 0012953649 scopus 로고    scopus 로고
    • Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study
    • Berning B, Kuijk CV, Kuiper JW, Bennink HJ, Kicovic PM, Fauser BC. Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: a two-year randomized, placebo-controlled study. Bone 1996;19:395-9.
    • (1996) Bone , vol.19 , pp. 395-399
    • Berning, B.1    Kuijk, C.V.2    Kuiper, J.W.3    Bennink, H.J.4    Kicovic, P.M.5    Fauser, B.C.6
  • 24
    • 0036123617 scopus 로고    scopus 로고
    • Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss
    • Roux C, Pelissier C, Fechtenbaum J, Loiseau-Peres S, Benhamou CL. Randomized, double-masked, 2-year comparison of tibolone with 17beta-estradiol and norethindrone acetate in preventing postmenopausal bone loss. Osteoporosis International 2002;13:241-8.
    • (2002) Osteoporosis International , vol.13 , pp. 241-248
    • Roux, C.1    Pelissier, C.2    Fechtenbaum, J.3    Loiseau-Peres, S.4    Benhamou, C.L.5
  • 26
    • 0029127973 scopus 로고
    • The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength - Assessed in a sexually mature, ovariectomized rat model
    • Mosekilde L, Danielsen CC, Sogaard CH, McOsker JE, Wronski TJ. The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength - assessed in a sexually mature, ovariectomized rat model. Bone 1995;16:223-30.
    • (1995) Bone , vol.16 , pp. 223-230
    • Mosekilde, L.1    Danielsen, C.C.2    Sogaard, C.H.3    McOsker, J.E.4    Wronski, T.J.5
  • 27
    • 0002693609 scopus 로고    scopus 로고
    • Effects of LY333334 (Recombinant parathyroid hormone (1-34)) on cortical bone strength indices as assessed by peripheral quantitative computed tomography
    • Program and abstracts of the 1st Joint Meeting of the International Bone and Mineral Society and the European Calcified Tissue Society; June 5-10, 2001; Madrid, Spain
    • Zanchetta JR, Bogado C, Ferretti JL, Wang O, Sato M, Gaich GA. Effects of LY333334 (Recombinant parathyroid hormone (1-34)) on cortical bone strength indices as assessed by peripheral quantitative computed tomography. Program and abstracts of the 1st Joint Meeting of the International Bone and Mineral Society and the European Calcified Tissue Society; June 5-10, 2001; Madrid, Spain. Bone 2001;28 Suppl:S86.
    • (2001) Bone , vol.28 , Issue.SUPPL.
    • Zanchetta, J.R.1    Bogado, C.2    Ferretti, J.L.3    Wang, O.4    Sato, M.5    Gaich, G.A.6
  • 29
    • 0030804947 scopus 로고    scopus 로고
    • Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis
    • Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, et al. Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis. Lancet 1997;350:550-5.
    • (1997) Lancet , vol.350 , pp. 550-555
    • Lindsay, R.1    Nieves, J.2    Formica, C.3    Henneman, E.4    Woelfert, L.5    Shen, V.6
  • 31
    • 18644374464 scopus 로고    scopus 로고
    • A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis
    • Body JJ, Gaich GA, Scheele WH, Kulkarni PM, Miller PD, Peretz A, et al. A randomized double-blind trial to compare the efficacy of teriparatide [recombinant human parathyroid hormone (1-34)] with alendronate in postmenopausal women with osteoporosis. Journal of Clinical Endocrinology and Metabolism 2002;87:4528-35.
    • (2002) Journal of Clinical Endocrinology and Metabolism , vol.87 , pp. 4528-4535
    • Body, J.J.1    Gaich, G.A.2    Scheele, W.H.3    Kulkarni, P.M.4    Miller, P.D.5    Peretz, A.6
  • 32
    • 0027316220 scopus 로고
    • An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats
    • Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, et al. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. Journal of Bone and Mineral Research 1993;8:607-15.
    • (1993) Journal of Bone and Mineral Research , vol.8 , pp. 607-615
    • Marie, P.J.1    Hott, M.2    Modrowski, D.3    De Pollak, C.4    Guillemain, J.5    Deloffre, P.6
  • 33
    • 0000848891 scopus 로고
    • The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclast cultures
    • Su Y, Bonet J, Deloffre P, Tsouderos Y, Baron R. The strontium salt S12911 inhibits bone resorption in mouse calvaria and isolated rat osteoclast cultures. Journal of Bone and Mineral Research 1992;17 Suppl 1:188.
    • (1992) Journal of Bone and Mineral Research , vol.17 , Issue.SUPPL. 1 , pp. 188
    • Su, Y.1    Bonet, J.2    Deloffre, P.3    Tsouderos, Y.4    Baron, R.5
  • 34
    • 0029812110 scopus 로고    scopus 로고
    • Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration
    • Boivin G, Deloffre P, Perrat B, Panczer G, Boudeulle M, Mauras Y, et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. Journal of Bone and Mineral Research 1996;11:1302-11.
    • (1996) Journal of Bone and Mineral Research , vol.11 , pp. 1302-1311
    • Boivin, G.1    Deloffre, P.2    Perrat, B.3    Panczer, G.4    Boudeulle, M.5    Mauras, Y.6
  • 38
    • 0029809357 scopus 로고    scopus 로고
    • Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency
    • Gelb BD, Shi GP, Chapman HA, Desnick RJ. Pycnodysostosis, a lysosomal disease caused by cathepsin K deficiency. Science 1996;273:1236-8.
    • (1996) Science , vol.273 , pp. 1236-1238
    • Gelb, B.D.1    Shi, G.P.2    Chapman, H.A.3    Desnick, R.J.4
  • 39
    • 4243893620 scopus 로고    scopus 로고
    • Effects of the TNF-alfa antibody imfliximab on serum markers of bone turnover and mineral metabolism in patients with rheumatoid arthritis
    • Dimai HP, Müller T, Eder S, Hermann J. Effects of the TNF-alfa antibody imfliximab on serum markers of bone turnover and mineral metabolism in patients with rheumatoid arthritis. Bone 2001;28:S179.
    • (2001) Bone , vol.28
    • Dimai, H.P.1    Müller, T.2    Eder, S.3    Hermann, J.4
  • 41
    • 0032835425 scopus 로고    scopus 로고
    • Vitamin D receptor gene polymorphisms and the risk of fractures in older women
    • For the Study of Osteoporotic Fractures Research Group
    • Ensrud KE, Stone K, Cauley JA, White C, Zmuda JM, Nguyen TV, et al. Vitamin D receptor gene polymorphisms and the risk of fractures in older women. For the Study of Osteoporotic Fractures Research Group. Journal of Bone and Mineral Research 1999;14:1637-45.
    • (1999) Journal of Bone and Mineral Research , vol.14 , pp. 1637-1645
    • Ensrud, K.E.1    Stone, K.2    Cauley, J.A.3    White, C.4    Zmuda, J.M.5    Nguyen, T.V.6
  • 42
    • 0141997792 scopus 로고    scopus 로고
    • Association of collagen type 1 (COL1A1) Sp 1 polymorphism with femoral neck bone mineral density and wrist fracture in elderly women
    • forthcoming
    • Gerdhem P, Brändström H, Stiger F, Obrant K, Melhus H, Ljunggren O, et al. Association of collagen type 1 (COL1A1) Sp 1 polymorphism with femoral neck bone mineral density and wrist fracture in elderly women. Calcified Tissue International 2003 (forthcoming).
    • (2003) Calcified Tissue International
    • Gerdhem, P.1    Brändström, H.2    Stiger, F.3    Obrant, K.4    Melhus, H.5    Ljunggren, O.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.